Sinovac Biotech Ltd. (SVA)
A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.
Recs
altheartist
(< 20)
Submitted: 11/25/2009 11:49:32 AM :
Start Price:
$7.45
SVA Score:
+2.09
People in China are getting sick .
Recs
OklaBoston
(< 20)
Submitted: 11/15/2009 10:10:26 PM :
Start Price:
$11.10
SVA Score:
-41.33
Scarily high P/E ratio, but the avg. P/E in this industry is even scarier. High growth industries tend to be that way.
Recs
plvo38
(< 20)
Submitted: 10/27/2009 11:19:10 AM :
Start Price:
$8.38
SVA Score:
-13.49
swine blu will spread, more and more cases reported, sva getting more orders weekly
Recs
sedaohr2
(< 20)
Submitted: 10/26/2009 11:36:39 AM :
Start Price:
$7.85
SVA Score:
-6.68
This a no-brainer with all the announcements about orders and shippments. Very good growth, and short term money that can be turned back into the company.
Recs
BEEST22
(< 20)
Submitted: 10/20/2009 10:27:15 AM :
Start Price:
$8.11
SVA Score:
-8.05
Swineflu is breaking out at the moment. A lot of vaccins will be needed !
Recs
cjang123
(< 20)
Submitted: 10/18/2009 1:17:37 PM :
Start Price:
$8.42
SVA Score:
-11.86
"China's 1.3 billion people + first H1N1 vaccine" give this one a winner for sure!
Recs
rwebankrupt
(97.88)
Submitted: 10/17/2009 7:29:05 PM :
Start Price:
$8.13
SVA Score:
-8.32
Sinovac Biotechnology is a great investment for combating Rabies in China.
Sinovac Biotechnology will be listed on the Hong Kong exchange sooner than later.
Sinovac Biotechnology will be listed on the Shanghai Exchange once 3 years of continuous profitabilty is achieved.
Rabies will always be a bigger problem for China than Swine Flu and while some wait for a buyout most wait for an Asian listing as Sinovac Biotechnology does not bite the hand that feeds them.
Recs
Kid6521
(23.48)
Submitted: 10/14/2009 7:10:34 AM :
Start Price:
$8.39
SVA Score:
-11.86
Exposure to Japan and China Flu markets is a great engine for growth
Recs
skino338
(< 20)
Submitted: 10/14/2009 6:33:48 AM :
Start Price:
$8.39
SVA Score:
-11.86
1.third orders will be coming end of this month
2.Q3 ER Nov 16th
Recs
malcolmcochran
(65.38)
Submitted: 10/10/2009 11:41:34 AM :
Start Price:
$7.84
SVA Score:
-6.42
1) Serious company, focused on single idea (vaccines) with many apps.
2) Vaccines are regaining importance
3) World's second biggest economy as its home market
4) Using best practice
5) Doggedly using US accounting rules
6) Home currency (yuan) can only rise against other denominations
7) Still has good metrics, and its H1N1 profit isn't yet in.
Recs
grants1
(< 20)
Submitted: 9/28/2009 7:46:29 PM :
Start Price:
$8.27
SVA Score:
-12.67
As different viruses become more prevelent and difficult to treat these vaccine makers will be more and more valuable. They are small and capable of adjusting to the markets needs faster than the large companies. This will continue to make them more valuable and attract big names to possibly buy them.
Recs
rbFreem
(< 20)
Submitted: 9/28/2009 11:29:09 AM :
Start Price:
$8.14
SVA Score:
-11.56
Future earnings powerhouse via front-line R&D-to-market products and expansion
Recs
DanishDynamite
(< 20)
Submitted: 9/23/2009 6:59:54 PM :
Start Price:
$8.68
SVA Score:
-17.11
Even though this stock went up with 700% since its' year low, it still has huge potential, they will have a record year, and they had revenue growth the last 2 years of average 74%, this year will be no different, with their H1N1 vaccine, this should be trading at high multiples, especially now when we enter the flu season.
Recs
59special
(< 20)
Submitted: 9/22/2009 10:23:03 PM :
Start Price:
$8.29
SVA Score:
-12.11
13/162 in Biotechnology -(67.4@A/A+)
Recs
ericcote1est
(34.93)
Submitted: 9/14/2009 6:36:44 PM :
Start Price:
$10.02
SVA Score:
-30.28
ccest compte
Recs
wedd26
(< 20)
Submitted: 9/11/2009 9:26:17 AM :
Start Price:
$9.71
SVA Score:
-28.33
it fulfills a human need, which is currently lacking.
Recs
Reasonablegifts
(22.54)
Submitted: 9/6/2009 11:58:42 AM :
Start Price:
$9.12
SVA Score:
-25.81
Two words (SWINE FLU)
Recs
jpsdvp27
(< 20)
Submitted: 9/4/2009 8:06:38 AM :
Start Price:
$9.50
SVA Score:
-30.96
strong company
Recs
RTFM2009
(36.16)
Submitted: 9/3/2009 5:06:27 PM :
Start Price:
$9.50
SVA Score:
-30.96
Slowly but surely it will get up there and reward those who hold on to it.
Recs
brentgre
(< 20)
Submitted: 9/1/2009 1:46:45 PM :
Start Price:
$11.29
SVA Score:
-43.95
High potential based on their current R&D pipeline.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 70 1 2 3 4 Next »